Print

Helix BioMedix, Inc. (HXBM) Reports Record 2011 Financial Results  
3/28/2012 7:09:08 AM

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the year ended December 31, 2011.

2011 Financial and Business Highlights

Revenue for 2011 increased 122% to a record $1.9 million, compared to $852,000 for 2010.

//-->